Drugs Made In America Acquisition II Corp. (DMIIR) — Stock Valuation & Research

Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.

DMIIR key statistics

Price$0.07
Market cap$4.68M
SectorFinancial Services
IndustryFinancial - Conglomerates
ExchangeNASDAQ
52-week range0.0667-0.0932
Beta2.05

Explore DMIIR's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.